K

Kilitch Drugs (India) Ltd
NSE:KILITCH

Watchlist Manager
Kilitch Drugs (India) Ltd
NSE:KILITCH
Watchlist
Price: 323.15 INR -0.46% Market Closed
Market Cap: 5.2B INR
Have any thoughts about
Kilitch Drugs (India) Ltd?
Write Note

Kilitch Drugs (India) Ltd
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kilitch Drugs (India) Ltd
Cash Interest Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
K
Kilitch Drugs (India) Ltd
NSE:KILITCH
Cash Interest Paid
â‚ą49.6m
CAGR 3-Years
110%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Cash Interest Paid
â‚ą2.9B
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Cash Interest Paid
â‚ą442.1m
CAGR 3-Years
-25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Cash Interest Paid
â‚ą2.2B
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Cash Interest Paid
â‚ą3.1B
CAGR 3-Years
-2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Cash Interest Paid
â‚ą261.7m
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Kilitch Drugs (India) Ltd
Glance View

Market Cap
5.2B INR
Industry
Pharmaceuticals

Kilitch Drugs (India) Ltd. engages in the manufacture and sale of pharmaceuticals, medicinal chemical, and botanical products. The company is headquartered in Mumbai, Maharashtra. The company is primarily engaged in the development, manufacturing, and marketing of finished dosages. The Company’s products include parenteral solutions, effervescent, nutritional products, and medical device. Its products categories include urinary alkalizer, cephalosporins products, gastroenterology, non steroidal anti-inflammatory drugs (NSAIDs), anticonvulsant/antiepileptic, adrenergic agonist, neurotonic, muscle relaxant/stimulant, aminoglycosides, anti-infective, anti-inflammatory, anti-malarials, anti-hypertensive, anaesthetic, uterine stimulants. Its parenteral solutions include neurotonic, veterinary products, metered nasal drops, vaccines, oncology, and ophthalmic products. Its effervescent products include Roipar, Duregra, And Roivit. The firm offers nutritional products, such as Celtine. The firm also offers medical devices, such as C-Seal.

KILITCH Intrinsic Value
251.63 INR
Overvaluation 22%
Intrinsic Value
Price
K

See Also

What is Kilitch Drugs (India) Ltd's Cash Interest Paid?
Cash Interest Paid
49.6m INR

Based on the financial report for Sep 30, 2024, Kilitch Drugs (India) Ltd's Cash Interest Paid amounts to 49.6m INR.

What is Kilitch Drugs (India) Ltd's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 3Y
110%

Over the last year, the Cash Interest Paid growth was 65%. The average annual Cash Interest Paid growth rates for Kilitch Drugs (India) Ltd have been 110% over the past three years .

Back to Top